Prediction of injury by limited and asymmetrical fundamental movement patterns in american football players.


Journal Article

CONTEXT: Previous injury is the strongest risk factor for future injury in sports. It has been proposed that motor-control changes such as movement limitation and asymmetry associated with injury and pain may be perpetuated as part of an individual's movement strategy. Motor control of fundamental 1-×-body-weight tasks can reliably and efficiently be measured in the field. OBJECTIVE: To determine whether the motor control of fundamental movement patterns and pattern asymmetry have a relationship with time-loss injury over the course of the preseason in professional football. DESIGN: Injury-risk study. SETTING: American professional football facilities. PARTICIPANTS: 238 American professional football players. INTERVENTION: To measure the motor control of 1-×-body-weight fundamental movement patterns, Functional Movement Screen scores were obtained before the start of training camp. The previously established cutoff score of ≤14 and the presence of any asymmetries on the FMS were examined using relative risk to determine if a relationship exists with time-loss injury. MAIN OUTCOME MEASURE: Time-loss musculoskeletal injury defined as any time loss from practice or competition due to musculoskeletal injury. RESULTS: Players who scored ≤14 exhibited a relative risk of 1.87 (CI95 1.202.96). Similarly, players with at least 1 asymmetry displayed a relative risk of 1.80 (CI95 1.112.74). The combination of scoring below the threshold and exhibiting a movement asymmetry was highly specific for injury, with a specificity of .87 (CI95 .84.90). CONCLUSION: The results of this study suggest that fundamental movement patterns and pattern asymmetry are identifiable risk factors for time-loss injury during the preseason in professional football players.

Full Text

Cited Authors

  • Kiesel, KB; Butler, RJ; Plisky, PJ

Published Date

  • May 2014

Published In

Volume / Issue

  • 23 / 2

Start / End Page

  • 88 - 94

PubMed ID

  • 24225032

Pubmed Central ID

  • 24225032

Electronic International Standard Serial Number (EISSN)

  • 1543-3072

International Standard Serial Number (ISSN)

  • 1056-6716

Digital Object Identifier (DOI)

  • 10.1123/jsr.2012-0130


  • eng